首页> 外文期刊>Journal of Food Science >Oral Toxicological Studies of Pueraria Flower Extract: Acute Toxicity Study in Mice and Subchronic Toxicity Study in Rats
【24h】

Oral Toxicological Studies of Pueraria Flower Extract: Acute Toxicity Study in Mice and Subchronic Toxicity Study in Rats

机译:葛根提取物的口服毒理学研究:小鼠急性毒性研究和大鼠亚慢性毒性研究

获取原文
获取原文并翻译 | 示例
           

摘要

Kudzu has been widely used as an herbal medicine in China. The root of the kudzu is also well known as an antipyretic and analgesic in treatment of the common cold, while its flower has been used to treat alcohol intoxication, alcohol abuse, and dysentery. Pueraria flower extract (PFE) is a hot water extract derived from the flower of the kudzu, Pueraria thomsonii Benth. (Fabaceae), oral intake of which exhibits anti-obesity properties in mice and humans. In this study, we conducted acute and subchronic toxicity studies for an evaluation of safety. In the acute study, PFE (5 g/kg body weight) was orally administered to ddY mice. For 14 d after administration, no deaths or abnormal changes were observed in general signs, body weight (BW), or food consumption, and no abnormal findings were observed in the major organs and tissues of either males or females at necropsy. The oral LD_(50) of PFE was therefore estimated to be higher than 5 g/kg BW In the subchronic study, PFE was mixed into the diet in place of powdered CRF-1 and administered at concentrations of 0% (control), 0.5%, 1.5%, and 5.0% to male and female Sprague-Dawley rats for 90 d. No mortality or toxicological changes were observed during the experimental period. Blood biochemical, hematological, and urinary parameters revealed no toxicologically significant changes. Furthermore, no anatomical or histopathological changes due to PFE were observed. The no-observed adverse-effect-level of PFE was thus estimated to be 5.0% in the diet (male: 3.0 g/kg BW/d; female: 3.5 g/kg BW/d).
机译:葛根在中国已被广泛用作草药。野葛的根在治疗普通感冒时也被称为解热镇痛药,而其花已被用于治疗酒精中毒,酗酒和痢疾。葛根花提取物(PFE)是从葛根的葛根花中提取的热水提取物。 (豆科),其口服摄入在小鼠和人类中表现出抗肥胖特性。在这项研究中,我们进行了急性和亚慢性毒性研究,以评估安全性。在急性研究中,对ddY小鼠口服PFE(5 g / kg体重)。给药后14 d,尸检时未观察到一般体征,体重(BW)或食物消耗的死亡或异常变化,在男性或女性的主要器官和组织中均未观察到异常发现。因此,估计口服PFE的LD_(50)高于5 g / kg体重。在亚慢性研究中,将PFE代替CRF-1粉末掺入饮食中,并以0%(对照),0.5雄性和雌性Sprague-Dawley大鼠在90 d内分别有%,1.5%和5.0%。在实验期间未观察到死亡率或毒理学变化。血液生化,血液学和尿液参数显示无毒理学显着变化。此外,未观察到由于PFE引起的解剖或组织病理学变化。因此,饮食中未观察到的PFE不良反应水平为5.0%(男性:3.0 g / kg体重/天;女性:3.5 g / kg体重/天)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号